• 08

• November

• 2023

Revance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics

LEARN MORE

• 03

• November

• 2023

Deloitte Unveils 2023 North America Technology Fast 500™ Rankings: Revance Named #3

LEARN MORE

• 01

• November

• 2023

Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

LEARN MORE

• 31

• October

• 2023

Injectable Neuromodulators & Fillers

LEARN MORE

• 26

• October

• 2023

DAXXIFY® Becomes First Facial Injectable to be Named to TIME’s Best Inventions

LEARN MORE

• 24

• October

• 2023

DAXXIFY Named to TIME® Best Inventions of 2023 List

LEARN MORE